Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal Microbiota Therapy vs Metronidazole for Primary CDI
NCT02301000Phase 3Terminated
- Sponsor
- Oslo University Hospital
- Start
- Feb 2015
- Primary completion
- Nov 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of anaerobically cultivated human intestinal microbiota in Clostridium difficile infection (CDI), sponsored by Oslo University Hospital. Started Feb 2015; status: terminated.
02
Drugs
anaerobically cultivated human intestinal microbiota
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02301000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301000.